Financial News
Press Releases about Lexaria Bioscience Corp
Lexaria Provides Update on Human Nicotine Study NIC-H22-1
April 12, 2022
Via AccessWire
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Lexaria Begins DehydraTECH-CBD Epilepsy Research Program
March 15, 2022
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Lexaria Granted Important New Oral Nicotine Patent
March 08, 2022
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.